drugset / Trial / NCT00360282

Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?

NCT00360282

RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.

Timeline

Start
2006-08
Primary completion
2009-01
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject rizatriptan Unknown 10 mg

Indications